We are live on !
Find out more
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
Turnover
42.78%
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter Est. Return
+19.41%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.38%
10 Year Est. Return
+875.18%
AUM
$80.2B
AUM Growth
+$3.12B
(+4%)
Cap. Flow
-$3.01B
Cap. Flow % of AUM
Cap. Flow %
-3.76%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
3,665
New
834
Increased
989
Reduced
995
Closed
734
Avg Time Held
Equity + Options
1.1
years
Top 10 Avg Time Held
Equity + Options
0.8
years
Top 20 Avg Time Held
Equity + Options
0.8
years
Avg Time Held Equity only
0.9
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 36.95% |
| 2 | Technology | 12.69% |
| 3 | Industrials | 9.95% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Healthcare | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
551
Summit Therapeutics
SMMT
$12.3B
| $27.7M | 0.03% |
1,904,254
+1,355,919
| +247% | +$24M |
2025 Q3
3 quarters
|
|
552
BellRing Brands
BRBR
$1.08B
| $27.7M | 0.03% |
2,140,109
+603,949
| +39% | +$7.29M |
2023 Q3
11 quarters
|
|
553
Delek US
DK
$4.27B
| $27.6M | 0.03% |
543,273
+98,062
| +22% | +$4.35M |
2025 Q4
2 quarters
|
|
554
First Horizon
FHN
$11B
| $27.5M | 0.03% |
1,072,255
-1,456,615
| -58% | -$35.5M |
2022 Q3
15 quarters
|
|
555
CALL
Caterpillar
CAT
$328B
| $27.5M | 0.03% |
25,800
+5,300
| +26% | +$4.66M |
2022 Q2
16 quarters
|
|
556
CALL
Wells Fargo
WFC
$251B
| $27.4M | 0.03% |
331,200
+140,600
| +74% | +$11.3M |
2023 Q3
11 quarters
|
|
557
Arrow Electronics
ARW
$11.1B
| $27.4M | 0.03% |
+128,186
| New | +$25.6M |
2026 Q2
0 quarters
|
|
558
SEI Investments
SEIC
$12.1B
| $27M | 0.03% |
308,050
+82,376
| +37% | +$7.19M |
2026 Q1
1 quarter
|
|
559
uniQure
QURE
$1.73B
| $27M | 0.03% |
586,582
-377,708
| -39% | -$9.9M |
2023 Q4
10 quarters
|
|
560
PUT
General Mills
GIS
$17.7B
| $27M | 0.03% |
775,000
+500,000
| +182% | +$17.3M |
2026 Q1
1 quarter
|
|
561
Alnylam Pharmaceuticals
ALNY
$30.1B
| $26.9M | 0.03% |
+89,510
| New | +$27M |
2026 Q2
0 quarters
|
|
562
Cemex
CX
$15.1B
| $26.9M | 0.03% |
+2,241,107
| New | +$27.8M |
2026 Q2
0 quarters
|
|
563
Ovintiv
OVV
$19.9B
| $26.9M | 0.03% |
510,610
+461,086
| +931% | +$26.3M |
2023 Q3
11 quarters
|
|
564
DELISTED
Select Medical
SEM
| $26.8M | 0.03% |
1,623,940
+719,203
| +79% | +$11.9M |
2025 Q4
2 quarters
|
|
565
CALL
Sunrun
RUN
$1.78B
| $26.8M | 0.03% |
+2,000,000
| New | +$27M |
2026 Q2
0 quarters
|
|
566
Reddit
RDDT
$26B
| $26.7M | 0.03% |
+153,630
| New | +$24.6M |
2026 Q2
0 quarters
|
|
567
CALL
CrowdStrike
CRWD
$272B
| $26.6M | 0.03% |
139,600
-136,000
| -49% | -$19.3M |
2023 Q1
13 quarters
|
|
568
Antero Resources
AR
$12.9B
| $26.5M | 0.03% |
752,717
+116,653
| +18% | +$4.29M |
2024 Q3
7 quarters
|
|
569
PUT
W.W. Grainger
GWW
$63.3B
| $26.1M | 0.03% |
19,200
-100
| -0.5% | -$123K |
2025 Q4
2 quarters
|
|
570
Faeth Therapeutics
FTH
$526M
| $26.1M | 0.03% |
1,042,198
+1,025,993
| +6,331% | +$23.7M |
2026 Q1
1 quarter
|
|
571
Applied Optoelectronics
AAOI
$6.74B
| $26M | 0.03% |
175,683
-293,187
| -63% | -$47.7M |
2025 Q3
3 quarters
|
|
572
Zscaler
ZS
$42.4B
| $26M | 0.03% |
+183,965
| New | +$25.6M |
2026 Q2
0 quarters
|
|
573
CALL
Marvell Technology
MRVL
$224B
| $25.9M | 0.03% |
87,100
-56,500
| -39% | -$11.3M |
2024 Q1
9 quarters
|
|
574
EyePoint Inc
EYPT
$33.9M
| $25.9M | 0.03% |
1,812,358
+373,621
| +26% | +$5M |
2025 Q3
3 quarters
|
|
575
Fabrinet
FN
$13B
| $25.8M | 0.03% |
45,847
+32,512
| +244% | +$21M |
2026 Q1
1 quarter
|
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $3.01B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.